ArticleCancer research2017
Open access · greenAbstract read
In one paragraph
Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 57 citations in OpenAlex.
- Murine modeling of IDH-mutant 1p/19q-codeleted oligodendroglioma reveals genotype specific phenotypes.bioRxiv : the preprint server for biology · 2026Article
- Modeling of Capicua Family Fusion Oncoprotein-Driven Cancers Reveals Gene-Specific Functionality.Molecular cancer research : MCR · 2026Article
- Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade.NPJ precision oncology · 2025Article
- IDH mutant high-grade gliomas.Frontiers in molecular neuroscience · 2025Review
- Exploring the Dual Roles of Neural Stem Cells in Glioblastoma: Therapeutic Implications and Opportunities.Current stem cell research & therapy · 2025Review
- Investigation of the correlation between AGRN expression and perineural invasion in colon cancer.Frontiers in molecular biosciences · 2024Article
- Tumor radiogenomics in gliomas with Bayesian layered variable selection.Medical image analysis · 2023Article
- Article
- Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity.Cancers · 2023Article
- CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.Acta neuropathologica communications · 2023Article
- Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Neuro-oncology · 2023Article
- Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors.Frontiers in oncology · 2023Article
- CIC missense variants contribute to susceptibility for spina bifida.Human mutation · 2022Article
- TheeLife · 2022Article
- CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.Cancers · 2022Review
- Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.Cell reports · 2022Article
- Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells.The Journal of pathology · 2022Article
- T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022Article
- Regulation of positive and negative selection and TCR signaling during thymic T cell development by capicua.eLife · 2021Article
- Molecular profiling of pediatric and adolescent ependymomas: identification of genetic variants using a next-generation sequencing panel.Journal of neuro-oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 1 institution in 1 country.
Rui YangDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Lee H ChenDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Landon J HansenDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Austin B CarpenterDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Casey J MoureDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Heng LiuDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Christopher J PirozziDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Bill H DiplasDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Matthew S WaitkusDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Paula K GreerDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Huishan ZhuDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Roger E McLendonDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Darell D BignerDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
Yiping HeDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina. hai.yan@duke.edu yiping.he@duke.edu.
Hai YanDepartment of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina. hai.yan@duke.edu yiping.he@duke.edu.
Duke University · US
Funding
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2MORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2MTraining Program in Developmental & Stem Cell BiologyT32HD040372 · NICHD · DUKE UNIVERSITY · PI Terry H Lechler · 2001 to 2026
$8.9MMedical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6MThe Role of IDH1 Mutations in Gliomagenesis and MetabolismR01CA140316 · NCI · DUKE UNIVERSITY · PI YAN, HAI · 2010 to 2019
$3.2MExploiting MTAP deletion for GBM therapeuticsR01NS101074 · NINDS · DUKE UNIVERSITY · PI HE, YIPING · 2017 to 2021
$1.7MExploring the therapeutic potential and pathogenic contribution of MTAP deletion in GlioblastomaF30CA206336 · NCI · DUKE UNIVERSITY · PI HANSEN, LANDON JOHN · 2017 to 2018
$85kNCI NIH HHS F30 CA206336NCI NIH HHS R01 CA140316NICHD NIH HHS T32 HD040372NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM007184NIGMS NIH HHS T32 GM145449NINDS NIH HHS R01 NS101074
Abstract
Inactivating mutations in the transcriptional repression factor
Indexed as
MutationAnimalsCell DifferentiationCell Line, TumorCell ProliferationCells, CulturedGene Expression ProfilingHumansMice, Inbred C57BLMice, Inbred NODMice, KnockoutMice, SCIDMice, TransgenicNeural Stem CellsOligodendrogliomaRepressor ProteinsCIC protein, humanCic protein, mouseRepressor Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.